Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cerevel Therapeutics Holdings, Inc. (CERE)  
$42.10 0.11 (0.26%) as of 4:30 Mon 4/22


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 156,320,000
Market Cap: 6.58(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $20.26 - $43.27
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 17,422,701 18,847,701
Total Buy Value $0 $0 $397,510,553 $447,385,553
Total People Bought 0 0 6 6
Total Buy Transactions 0 0 6 7
Total Shares Sold 154,667 459,132 661,027 1,200,893
Total Sell Value $6,418,967 $16,606,452 $22,577,151 $39,590,443
Total People Sold 2 8 8 10
Total Sell Transactions 5 23 28 48
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 181
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Coles N Anthony   –       •      –    2024-04-01 4 AS $42.33 $2,116,640 D/D (50,000) 15,638 -0%     
   Coles N Anthony   –       •      –    2024-04-01 4 OE $3.50 $175,000 D/D 50,000 65,638     -
   Coles N Anthony   –       •      –    2024-03-04 4 AS $41.01 $2,050,550 D/D (50,000) 15,638 3%     
   Coles N Anthony   –       •      –    2024-03-04 4 OE $3.50 $175,000 D/D 50,000 65,638     -
   Coles N Anthony   –       •      –    2024-02-29 4 AS $41.16 $2,057,890 D/D (50,000) 15,638 3%     
   Coles N Anthony   –       •      –    2024-02-29 4 OE $3.50 $175,000 D/D 50,000 65,638     -
   Edelman Joseph Director   –       •      –    2024-02-20 4 GD $0.00 $0 I/I 170,317 0     -
   Renger John Chief Scientific Officer   •       –      –    2024-02-07 4 S $41.54 $89,777 D/D (2,161) 6,370 -2%     
   Coles N Anthony   –       •      –    2024-02-07 4 S $41.54 $104,110 D/D (2,506) 15,638 -2%     
   Renger John Chief Scientific Officer   •       –      –    2024-02-06 4 OE $0.00 $0 D/D 5,020 8,531     -
   Coles N Anthony   –       •      –    2024-02-06 4 OE $0.00 $0 D/D 15,440 18,144     -
   Coles N Anthony   –       •      –    2024-01-02 4 AS $42.24 $2,111,815 D/D (50,000) 2,704     -
   Coles N Anthony   –       •      –    2024-01-02 4 OE $3.50 $175,000 D/D 50,000 52,704     -
   Tregoning Kathleen See Remarks   •       –      –    2023-12-26 4 OE $10.05 $31,658 D/D 3,150 10,666     -
   Sanchez Ramiro Chief Medical Officer   •       –      –    2023-12-26 4 AS $42.47 $424,700 D/D (10,000) 14,673 -0%     
   Sanchez Ramiro Chief Medical Officer   •       –      –    2023-12-26 4 OE $3.50 $35,000 D/D 10,000 24,673     -
   Dipietro Kenneth Chief Human Resources Officer   •       –      –    2023-12-22 4 S $41.45 $331,608 D/D (8,000) 24,663 -1%     
   Dipietro Kenneth Chief Human Resources Officer   •       –      –    2023-12-22 4 OE $3.50 $28,000 D/D 8,000 32,663     -
   Akamine Scott Chief Legal Officer   •       –      –    2023-12-20 4 S $41.42 $292,945 D/D (7,072) 7,237 -2%     
   Dipietro Kenneth Chief Human Resources Officer   •       –      –    2023-12-20 4 S $41.42 $259,144 D/D (6,256) 24,663 -2%     
   Tregoning Kathleen See Remarks   •       –      –    2023-12-20 4 S $41.42 $260,469 D/D (6,288) 7,516 -2%     
   Sanchez Ramiro Chief Medical Officer   •       –      –    2023-12-20 4 S $41.42 $420,528 D/D (10,152) 14,673 -2%     
   Bodenrader Mark See Remarks   •       –      –    2023-12-20 4 S $41.42 $326,788 D/D (7,889) 17,724 -2%     
   Altschuller Susan Chief Financial Officer   •       –      –    2023-12-20 4 S $41.42 $571,972 D/D (13,808) 16,913 -2%     
   Burgess Paul D. See Remarks   •       –      –    2023-12-19 4 OE $0.00 $0 D/D 23,847 45,727     -
  181 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us